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Introduction
As the coronavirus-2019 (COVID-19,1) epidemic continues 
to spread worldwide, there is mounting pressure to assess the 
scale of epidemics in newly affected countries as rapidly as 
possible. We introduce a method for estimating cases from 
recently reported COVID-19 deaths. Results suggest that by 
the time the first deaths have been reported, there may be 
hundreds to thousands of cases in the affected population. We 
provide epidemic size estimates for several countries, and a 
user-friendly, web-based tool that implements our model2.
Methods
Using deaths to infer cases
COVID-19 deaths start to be notified in countries where few 
or no cases had previously been reported3. Given the non-
specific symptoms4, and the high rate of mild disease5, a 
COVID-19 epidemic may go unnoticed in a new location until 
the first severe cases or deaths are reported6. Available estimates 
of the case fatality ratio, i.e. the proportion of cases that are 
fatal (CFR,7,8), can be used to estimate the number of cases who 
would have shown symptoms at the same time as the fatal cases. 
We developed a model to use CFR alongside other epidemio-
logical factors underpinning disease transmission to infer the 
likely number of cases in a population from newly reported 
deaths.
Our approach involves two steps: first, reconstructing historic 
cases by assuming non-fatal cases are all undetected, and, sec-
ond, model epidemic growth from these cases until the present 
day to estimate the likely number of current cases. We account 
for uncertainty in the epidemiological processes by using 
stochastic simulations for estimation of relevant quantities.
Two pieces of information are needed to reconstruct past cases: 
the number of cases for each reported death, and their dates 
of symptom onset. Intuitively, the CFR provides some infor-
mation on the number of cases, as it represents the expected 
number of deaths per case, so that CFR-1 corresponds to the 
expected number of cases per death. In practice, the number 
of cases until the first reported death can be drawn from a 
Geometric distribution with an event probability equal to the 
CFR. Note that while our approach could in theory use differ-
ent CFR for each case (to account for different risk groups), 
our current implementation uses the same CFR for all cases in 
a simulation. Dates of symptom onset are simulated from the 
distribution of the time from onset to death, modelled as a 
discretised Gamma distribution with a mean of 15 days and a 
standard deviation of 6.9 days9.
Once past cases are reconstructed, we use a branching proc-
ess model for forecasting new cases10,11. This model combines 
data on the reproduction number (R) and serial interval dis-
tribution to simulate new cases ‘y
t
’ on day ‘t’ from a Poisson 
distribution: 
             ( ) ( )1 poisson witht t t s t sy R y w t sλ λ+ ≤= ∑ −∼              
where w(.) is the probability mass function of the serial inter-
val distribution. More details on this simulation model can 
be found in Jombart et al.11. Optionally, this model can also 
incorporate heterogeneity in transmissibility using a Negative 
Binomial distribution instead of Poisson. The serial interval dis-
tribution was characterized as a discretized Lognormal distribu-
tion with mean 4.7 days and standard deviation 2.9 days12. We 
assume that past cases caused secondary transmissions 
independently (i.e. are not ancestral to each other), so that 
simulated cases for each death can be added. This assump-
tion is most likely to be met when reported deaths are close 
in time. As the time between reported deaths increases, past 
cases may come from the same epidemic trajectory rather 
than separate, additive ones, in which case our method would 
overpredict epidemic size.
Further details on model design and parameters values are 
provided in Supplementary Material. Our approach is imple-
mented in the R software13 and publicly available as R scripts 
(see Extended data)14, as well as in a user-friendly, interactive 
web-interface available at: https://cmmid.github.io/visualisations/
inferring-covid19-cases-from-deaths2.
Results
How many cases for a single death?
We first used our model to assess likely epidemic sizes when 
an initial COVID-19 death is reported in a new location. We 
ran simulations for a range of plausible values of R (1.5, 2 
and 3) and CFR (1%, 2%, 3% and 10%), assuming a single 
death on the 1st March 20208. 25,000 epidemic trajectories 
were simulated for each parameter combination. Simulations 
for an ‘average severity’ scenario8 with R = 2 and CFR = 2% 
show that by the time a death has occurred, hundreds to thou-
sands of cases may have been generated in the affected 
population (Figure 1). Results vary widely across other param-
eter settings, and amongst simulations from a given setting 
(Table 1), with higher R and lower CFR leading to higher 
estimates of the numbers of cases. However, a majority of 
settings give similar results to our ‘average’ scenario, suggest-
ing that a single death is likely to reflect several hundreds of 
cases. Results were qualitatively unchanged when incorporat-
ing heterogeneity in the model using recent estimates15, but 
prediction intervals were wider (Extended data).
Recently affected countries
We applied our approach to three countries which recently 
reported their first COVID-19 deaths (Spain, Italy, and France), 
using the same range of parameters as in the single-death analy-
sis. In order to compare predictions to cases actually reported 
in these countries, projections were run until 4th March. Over-
all, predictions from the model using the baseline scenario 
(R = 2, CRF = 2%) were in line with reported epidemic sizes 
(Table 2). Results from other scenarios are presented in the 
Extended data. Actual numbers of reported cases fell within 
the 50% quantile intervals of simulations in all three countries 
Italy (median: 1 294 ; QI
50%
: [390 ; 3 034]; reported: 2 037), 
France (median: 592 ; QI
50%
: [177 ; 1 705]; reported: 190) 
and Spain, (median: 202 ; QI
50%
: [95 ; 823]; reported 202).
Discussion
Several limitations need to be considered when apply-
ing our method. First, our approach only applies to the 
deaths of patients who have become symptomatic in the 
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Table 1. Inferred number of cases for a single death. Inferred number of cases after detection of a single 
death under different values of the reproduction number, and case fatality ratio. We estimate the number 
of expected cases in the population at the day the death occurred, and present median, 50%, and 95% 
estimates of the quantile interval.
R Median Lower 95% Quantile 
Interval
Lower 50% Quantile 
Interval
Upper 50% Quantile 
Interval
Upper 95% Quantile 
Interval
CFR 1%
1.5 252 5 102 596 2 572
2 519 9 174 1 477 8 325
3 1 733 37 541 7 461 138 624
CFR 2%
1.5 132 2 52 294 1,110
2 276 5 93 780 5 694
3 964 19 300 4 174 49 137
CFR 3%
1.5 75 2 27 191 757
2 181 4 60 465 2 515
3 719 7 173 3 100 89 909
CFR 10%
1.5 29 0 10 65 219
2 46 0 15 136 1,020
3 245 2 63 983 30 708
Figure 1. Example of simulated epidemic trajectories from a single death. This figure shows results of 200 simulations using a CFR of 2% 
and R of 2 based on a hypothetical situation where a single death occurred on the 1st March 2020, represented by the red line. Ribbons of 
different shades represent, from the lightest to the darkest, the 95%, 75%, 50% and 25% quantile intervals.
location considered, which should usually be the case in places 
where traveler screening is in place. We also assume constant 
transmissibility (R) over time, which implies that behavior 
changes and control measures have not taken place yet, and that 
there is no depletion of susceptible individuals. Consequently, 
our method should only be used in the early stages of a new 
epidemic, where these assumptions are reasonable. Similarly, 
the assumption that each death reflects independent, additive 
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epidemic trajectories is most likely to hold true early on, 
when reported deaths are close in time (e.g. no more than a 
week apart). Used on deaths spanning longer time periods, 
our approach is likely to overestimate epidemic sizes.
Contact tracing has been shown to be an efficient control meas-
ure when imported cases can be detected early on 16, in addi-
tion to permitting the estimation of key epidemiological 
parameters12. When the first cases reported in a new location 
are mostly deaths, however, our results suggest that theunderly-
ing size of the epidemic would make control via contact tracing 
extremely challenging. In such situations, efforts focusing 
on social distancing measures such as schoolclosures and 
self-isolation may be more likely to mitigate epidemic spread. 
Data availability
Underlying data
All data underlying the results are available as part of the article 
and no additional source data are required.
Extended data
Zenodo: Extended data for: Inferring the number of 
COVID-19 cases from recently reported deaths. http://doi.
org/10.5281/zenodo.373328914.
This project contains the file ‘extended_data’ (PDF), which con-
tains supplemental information and methodological details 
regarding the model described in this article.
Extended data are available under the terms of the Creative Com-
mons Attribution 4.0 International license (CC-BY 4.0).
Software availability
The Shiny app using the model is available at: https://cmmid.
github.io/visualisations/inferring-covid19-cases-from-deaths.
Source code and R scripts available at: https://github.com/thibau-
tjombart/covid19_cases_from_deaths.
Archived code at time of publication: http://doi.org/10.5281/zen-
odo.37330472.
License: Code is available under an MIT License; other 
documentation is available under a CC-BY 4.0 License.
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Table 2. Inferred number of cases for several countries assuming CFR of 2% and R of 2. All values 
are presented for the 4th of March 2020 for different countries. We present the predicted case counts as 





















Spain 4th March 1 202 263 8 95 823 7 829
Italy 26th Feb 1 2 037 1 294 33 390 3 034 19 487
France 21st Feb 1 190 592 10 177 1 705 7 501
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